{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T17:22:46Z","timestamp":1793985766188,"version":"4.8.0"},"reference-count":96,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T00:00:00Z","timestamp":1759363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T00:00:00Z","timestamp":1759363200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"This work was supported by Center for Cancer Research (CCR), part of NCI\u2019s intramural research program, NIH, Department of Health and Human Services (DHHS)."}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Cardiovasc Res"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Heart disease, a leading cause of mortality worldwide, is in urgent need of improved therapies. Fibrosis, an accumulation of collagen-rich extracellular matrix in response to injury, is a hallmark of heart disease, but clinical agents that can interfere with the fibrotic pathway do not yet exist. Here we show that ANTXR1\/TEM8, a pathology-induced transmembrane protein required for collagen removal, exacerbates injury in multiple models of heart failure. Genetic disruption of\n                    <jats:italic>Antxr1<\/jats:italic>\n                    and treatment with human neutralizing antibodies prevented heart deterioration following acute myocardial infarction. ANTXR1 pharmacological blockade also improved heart function in models of pressure overload and obesity-induced heart disease with preserved ejection fraction. Improved heart function was accompanied by enhanced exercise tolerance. Mechanistic studies revealed an ANTXR1-antibody-driven improvement in post-infarct scar formation followed by attenuation of late-stage, chronic TGF\u03b2-mediated extracellular matrix remodeling. Thus, ANTXR1-mediated collagen turnover during heart failure is both maladaptive and druggable, providing avenues for therapeutic intervention.\n                  <\/jats:p>","DOI":"10.1038\/s44161-025-00725-y","type":"journal-article","created":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T09:04:55Z","timestamp":1759395895000},"page":"1521-1538","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["ANTXR1 blockade enhances cardiac function in preclinical models of heart failure"],"prefix":"10.1038","volume":"4","author":[{"given":"Nicola","family":"Boccella","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"GuoJun","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3349-3334","authenticated-orcid":false,"given":"Steven","family":"Seaman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2267-6717","authenticated-orcid":false,"given":"Jaewon","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Tomassoni-Ardori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liping","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kuo-Sheng","family":"Hsu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James M.","family":"Dunleavey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jodi","family":"Becker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary Beth","family":"Hilton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen","family":"Morris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niza","family":"Borchin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daeho","family":"So","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pradip","family":"Bajgain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sudhirkumar","family":"Yanpallewar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4849-0371","authenticated-orcid":false,"given":"Ryan T.","family":"Gross","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Krish C.","family":"Dewan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dawn E.","family":"Bowles","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0054-6607","authenticated-orcid":false,"given":"Darren A.","family":"Yuen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6420-772X","authenticated-orcid":false,"given":"Lino","family":"Tessarollo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6246-0374","authenticated-orcid":false,"given":"Brad","family":"St. Croix","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,2]]},"reference":[{"key":"725_CR1","doi-asserted-by":"publisher","first-page":"2982","DOI":"10.1016\/j.jacc.2020.11.010","volume":"76","author":"GA Roth","year":"2020","unstructured":"Roth, G. A. et al. Global burden of cardiovascular diseases and risk factors, 1990-2019: update from the GBD 2019 study. J. Am. Coll. Cardiol. 76, 2982\u20133021 (2020).","journal-title":"J. Am. Coll. Cardiol."},{"key":"725_CR2","doi-asserted-by":"publisher","first-page":"2361","DOI":"10.1016\/j.jacc.2022.11.005","volume":"80","author":"M Vaduganathan","year":"2022","unstructured":"Vaduganathan, M., Mensah, G. A., Turco, J. V., Fuster, V. & Roth, G. A. The global burden of cardiovascular diseases and risk: a compass for future health. J. Am. Coll. Cardiol. 80, 2361\u20132371 (2022).","journal-title":"J. Am. Coll. Cardiol."},{"key":"725_CR3","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1038\/s41586-019-1100-z","volume":"568","author":"GG Schiattarella","year":"2019","unstructured":"Schiattarella, G. G. et al. Nitrosative stress drives heart failure with preserved ejection fraction. Nature 568, 351\u2013356 (2019).","journal-title":"Nature"},{"key":"725_CR4","doi-asserted-by":"publisher","first-page":"1450","DOI":"10.1093\/cvr\/cvaa324","volume":"117","author":"NG Frangogiannis","year":"2021","unstructured":"Frangogiannis, N. G. Cardiac fibrosis. Cardiovasc Res. 117, 1450\u20131488 (2021).","journal-title":"Cardiovasc Res."},{"key":"725_CR5","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1161\/CIRCRESAHA.115.306565","volume":"118","author":"JG Travers","year":"2016","unstructured":"Travers, J. G., Kamal, F. A., Robbins, J., Yutzey, K. E. & Blaxall, B. C. Cardiac fibrosis: the fibroblast awakens. Circ. Res. 118, 1021\u20131040 (2016).","journal-title":"Circ. Res."},{"key":"725_CR6","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1038\/s41569-021-00646-w","volume":"19","author":"NG Frangogiannis","year":"2022","unstructured":"Frangogiannis, N. G. Transforming growth factor-\u03b2 in myocardial disease. Nat. Rev. Cardiol. 19, 435\u2013455 (2022).","journal-title":"Nat. Rev. Cardiol."},{"key":"725_CR7","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1038\/s41569-020-00504-1","volume":"18","author":"B Lopez","year":"2021","unstructured":"Lopez, B. et al. Diffuse myocardial fibrosis: mechanisms, diagnosis and therapeutic approaches. Nat. Rev. Cardiol. 18, 479\u2013498 (2021).","journal-title":"Nat. Rev. Cardiol."},{"key":"725_CR8","doi-asserted-by":"publisher","first-page":"6021","DOI":"10.1158\/0008-5472.CAN-09-1086","volume":"69","author":"M Cullen","year":"2009","unstructured":"Cullen, M. et al. Host-derived tumor endothelial marker 8 promotes the growth of melanoma. Cancer Res. 69, 6021\u20136026 (2009).","journal-title":"Cancer Res."},{"key":"725_CR9","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-34643-5","volume":"13","author":"KS Hsu","year":"2022","unstructured":"Hsu, K. S. et al. Cancer cell survival depends on collagen uptake into tumor-associated stroma. Nat. Commun. 13, 7078 (2022).","journal-title":"Nat. Commun."},{"key":"725_CR10","doi-asserted-by":"publisher","first-page":"1197","DOI":"10.1126\/science.289.5482.1197","volume":"289","author":"B St Croix","year":"2000","unstructured":"St Croix, B. et al. Genes expressed in human tumor endothelium. Science 289, 1197\u20131202 (2000).","journal-title":"Science"},{"key":"725_CR11","doi-asserted-by":"publisher","first-page":"2927","DOI":"10.1172\/JCI120481","volume":"128","author":"C Szot","year":"2018","unstructured":"Szot, C. et al. Tumor stroma-targeted antibody-drug conjugate triggers localized anticancer drug release. J. Clin. Invest. 128, 2927\u20132943 (2018).","journal-title":"J. Clin. Invest."},{"key":"725_CR12","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1158\/0008-5472.CAN-03-2408","volume":"64","author":"A Nanda","year":"2004","unstructured":"Nanda, A. et al. TEM8 interacts with the cleaved C5 domain of collagen \u03b1 3(VI). Cancer Res. 64, 817\u2013820 (2004).","journal-title":"Cancer Res."},{"key":"725_CR13","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1016\/j.ccr.2012.01.004","volume":"21","author":"A Chaudhary","year":"2012","unstructured":"Chaudhary, A. et al. TEM8\/ANTXR1 blockade inhibits pathological angiogenesis and potentiates tumoricidal responses against multiple cancer types. Cancer Cell 21, 212\u2013226 (2012).","journal-title":"Cancer Cell"},{"key":"725_CR14","doi-asserted-by":"publisher","first-page":"e0146586","DOI":"10.1371\/journal.pone.0146586","volume":"11","author":"NJ Andersen","year":"2016","unstructured":"Andersen, N. J. et al. Anthrax toxin receptor 1 is essential for arteriogenesis in a mouse model of hindlimb ischemia. PLoS ONE 11, e0146586 (2016).","journal-title":"PLoS ONE"},{"key":"725_CR15","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1016\/j.ajhg.2013.03.023","volume":"92","author":"V Stranecky","year":"2013","unstructured":"Stranecky, V. et al. Mutations in ANTXR1 cause GAPO syndrome. Am. J. Hum. Genet. 92, 792\u2013799 (2013).","journal-title":"Am. J. Hum. Genet."},{"key":"725_CR16","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.matbio.2014.12.002","volume":"42","author":"TY Besschetnova","year":"2015","unstructured":"Besschetnova, T. Y. et al. Regulatory mechanisms of anthrax toxin receptor 1-dependent vascular and connective tissue homeostasis. Matrix Biol. 42, 56\u201373 (2015).","journal-title":"Matrix Biol."},{"key":"725_CR17","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1038\/s44161-022-00028-6","volume":"1","author":"AL Koenig","year":"2022","unstructured":"Koenig, A. L. et al. Single-cell transcriptomics reveals cell-type-specific diversification in human heart failure. Nat. Cardiovasc. Res. 1, 263\u2013280 (2022).","journal-title":"Nat. Cardiovasc. Res."},{"key":"725_CR18","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1038\/s41586-022-04817-8","volume":"608","author":"M Chaffin","year":"2022","unstructured":"Chaffin, M. et al. Single-nucleus profiling of human dilated and hypertrophic cardiomyopathy. Nature 608, 174\u2013180 (2022).","journal-title":"Nature"},{"key":"725_CR19","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1016\/j.ddmod.2007.11.002","volume":"4","author":"RD Patten","year":"2007","unstructured":"Patten, R. D. Models of gender differences in cardiovascular disease. Drug Discov. Today Dis. Models 4, 227\u2013232 (2007).","journal-title":"Drug Discov. Today Dis. Models"},{"key":"725_CR20","unstructured":"American Heart Association. Heart failure. https:\/\/www.heart.org\/en\/health-topics\/heart-failure."},{"key":"725_CR21","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1016\/S0735-1097(03)00578-3","volume":"42","author":"C Boixel","year":"2003","unstructured":"Boixel, C. et al. Fibrosis of the left atria during progression of heart failure is associated with increased matrix metalloproteinases in the rat. J. Am. Coll. Cardiol. 42, 336\u2013344 (2003).","journal-title":"J. Am. Coll. Cardiol."},{"key":"725_CR22","doi-asserted-by":"publisher","first-page":"3900","DOI":"10.1074\/jbc.M116.767749","volume":"292","author":"M Lo","year":"2017","unstructured":"Lo, M. et al. Effector-attenuating substitutions that maintain antibody stability and reduce toxicity in mice. J. Biol. Chem. 292, 3900\u20133908 (2017).","journal-title":"J. Biol. Chem."},{"key":"725_CR23","doi-asserted-by":"publisher","first-page":"113503","DOI":"10.1016\/j.celrep.2023.113503","volume":"42","author":"Y Feng","year":"2023","unstructured":"Feng, Y. et al. Engineering CD276\/B7-H3-targeted antibody-drug conjugates with enhanced cancer-eradicating capability. Cell Rep. 42, 113503 (2023).","journal-title":"Cell Rep."},{"key":"725_CR24","doi-asserted-by":"publisher","first-page":"1448","DOI":"10.1161\/CIRCULATIONAHA.119.045115","volume":"142","author":"MA McLellan","year":"2020","unstructured":"McLellan, M. A. et al. High-resolution transcriptomic profiling of the heart during chronic stress reveals cellular drivers of cardiac fibrosis and hypertrophy. Circulation 142, 1448\u20131463 (2020).","journal-title":"Circulation"},{"key":"725_CR25","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1038\/nature24676","volume":"552","author":"S Schafer","year":"2017","unstructured":"Schafer, S. et al. IL-11 is a crucial determinant of cardiovascular fibrosis. Nature 552, 110\u2013115 (2017).","journal-title":"Nature"},{"key":"725_CR26","doi-asserted-by":"publisher","first-page":"1556","DOI":"10.1016\/j.jacc.2016.01.030","volume":"67","author":"D Jeong","year":"2016","unstructured":"Jeong, D. et al. Matricellular protein CCN5 reverses established cardiac fibrosis. J. Am. Coll. Cardiol. 67, 1556\u20131568 (2016).","journal-title":"J. Am. Coll. Cardiol."},{"key":"725_CR27","doi-asserted-by":"publisher","first-page":"1831","DOI":"10.1161\/CIRCULATIONAHA.119.044557","volume":"142","author":"A Ruiz-Villalba","year":"2020","unstructured":"Ruiz-Villalba, A. et al. Single-cell RNA sequencing analysis reveals a crucial role for CTHRC1 (collagen triple helix repeat containing 1) cardiac fibroblasts after myocardial infarction. Circulation 142, 1831\u20131847 (2020).","journal-title":"Circulation"},{"key":"725_CR28","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1007\/s00395-013-0374-9","volume":"108","author":"Y Huang","year":"2013","unstructured":"Huang, Y. et al. Deficiency of cartilage oligomeric matrix protein causes dilated cardiomyopathy. Basic Res. Cardiol. 108, 374 (2013).","journal-title":"Basic Res. Cardiol."},{"key":"725_CR29","doi-asserted-by":"publisher","first-page":"H1486","DOI":"10.1152\/ajpheart.00046.2016","volume":"310","author":"T Palao","year":"2016","unstructured":"Palao, T. et al. Thrombospondin-4 knockout in hypertension protects small-artery endothelial function but induces aortic aneurysms. Am. J. Physiol. Heart Circ. Physiol. 310, H1486\u2013H1493 (2016).","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"725_CR30","doi-asserted-by":"crossref","unstructured":"Thavapalachandran, S. et al. Platelet-derived growth factor-AB improves scar mechanics and vascularity after myocardial infarction. Sci. Transl. Med. 12 (2020).","DOI":"10.1126\/scitranslmed.aay2140"},{"key":"725_CR31","doi-asserted-by":"publisher","first-page":"223ra221","DOI":"10.1126\/scitranslmed.3007244","volume":"6","author":"SR Eckhouse","year":"2014","unstructured":"Eckhouse, S. R. et al. Local hydrogel release of recombinant TIMP-3 attenuates adverse left ventricular remodeling after experimental myocardial infarction. Sci. Transl. Med. 6, 223ra221 (2014).","journal-title":"Sci. Transl. Med."},{"key":"725_CR32","doi-asserted-by":"publisher","first-page":"H1012","DOI":"10.1152\/ajpheart.00246.2010","volume":"299","author":"V Kandalam","year":"2010","unstructured":"Kandalam, V. et al. Early activation of matrix metalloproteinases underlies the exacerbated systolic and diastolic dysfunction in mice lacking TIMP3 following myocardial infarction. Am. J. Physiol. Heart Circ. Physiol. 299, H1012\u2013H1023 (2010).","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"725_CR33","doi-asserted-by":"publisher","first-page":"e0166480","DOI":"10.1371\/journal.pone.0166480","volume":"11","author":"J Kim","year":"2016","unstructured":"Kim, J. et al. Cytokine-like 1 regulates cardiac fibrosis via modulation of TGF-\u03b2 signaling. PLoS ONE 11, e0166480 (2016).","journal-title":"PLoS ONE"},{"key":"725_CR34","doi-asserted-by":"publisher","unstructured":"Kuwabara, J. T. et al. Consequences of PDGFR\u03b1(+) fibroblast reduction in adult murine hearts. Elife https:\/\/doi.org\/10.7554\/eLife.69854 (2022).","DOI":"10.7554\/eLife.69854"},{"key":"725_CR35","doi-asserted-by":"publisher","first-page":"951704","DOI":"10.3389\/fcvm.2022.951704","volume":"9","author":"H Rui","year":"2022","unstructured":"Rui, H., Zhao, F., Yuhua, L. & Hong, J. Suppression of SMOC2 alleviates myocardial fibrosis via the ILK\/p38 pathway. Front. Cardiovasc. Med. 9, 951704 (2022).","journal-title":"Front. Cardiovasc. Med."},{"key":"725_CR36","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1084\/jem.20071297","volume":"205","author":"M Shimazaki","year":"2008","unstructured":"Shimazaki, M. et al. Periostin is essential for cardiac healing after acute myocardial infarction. J. Exp. Med. 205, 295\u2013303 (2008).","journal-title":"J. Exp. Med."},{"key":"725_CR37","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1161\/CIRCRESAHA.107.149047","volume":"101","author":"T Oka","year":"2007","unstructured":"Oka, T. et al. Genetic manipulation of periostin expression reveals a role in cardiac hypertrophy and ventricular remodeling. Circ. Res. 101, 313\u2013321 (2007).","journal-title":"Circ. Res."},{"key":"725_CR38","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/j.yjmcc.2008.05.005","volume":"45","author":"B Wang","year":"2008","unstructured":"Wang, B. et al. The Kruppel-like factor KLF15 inhibits connective tissue growth factor (CTGF) expression in cardiac fibroblasts. J. Mol. Cell. Cardiol. 45, 193\u2013197 (2008).","journal-title":"J. Mol. Cell. Cardiol."},{"key":"725_CR39","doi-asserted-by":"publisher","first-page":"14730","DOI":"10.1073\/pnas.94.26.14730","volume":"94","author":"PM Oliver","year":"1997","unstructured":"Oliver, P. M. et al. Hypertension, cardiac hypertrophy, and sudden death in mice lacking natriuretic peptide receptor A. Proc. Natl Acad. Sci. USA 94, 14730\u201314735 (1997).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"725_CR40","doi-asserted-by":"publisher","first-page":"e24872","DOI":"10.1371\/journal.pone.0024872","volume":"6","author":"H Iwasaki","year":"2011","unstructured":"Iwasaki, H. et al. PlGF repairs myocardial ischemia through mechanisms of angiogenesis, cardioprotection and recruitment of myo-angiogenic competent marrow progenitors. PLoS ONE 6, e24872 (2011).","journal-title":"PLoS ONE"},{"key":"725_CR41","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1038\/s41586-021-03674-1","volume":"595","author":"M Alexanian","year":"2021","unstructured":"Alexanian, M. et al. A transcriptional switch governs fibroblast activation in heart disease. Nature 595, 438\u2013443 (2021).","journal-title":"Nature"},{"key":"725_CR42","doi-asserted-by":"publisher","first-page":"952","DOI":"10.1038\/nm1613","volume":"13","author":"EM Zeisberg","year":"2007","unstructured":"Zeisberg, E. M. et al. Endothelial-to-mesenchymal transition contributes to cardiac fibrosis. Nat. Med. 13, 952\u2013961 (2007).","journal-title":"Nat. Med."},{"key":"725_CR43","doi-asserted-by":"publisher","first-page":"958","DOI":"10.1161\/HYPERTENSIONAHA.111.183905","volume":"59","author":"K Okayama","year":"2012","unstructured":"Okayama, K. et al. Hepatocyte growth factor reduces cardiac fibrosis by inhibiting endothelial-mesenchymal transition. Hypertension 59, 958\u2013965 (2012).","journal-title":"Hypertension"},{"key":"725_CR44","doi-asserted-by":"publisher","first-page":"652","DOI":"10.1161\/CIRCHEARTFAILURE.114.001113","volume":"7","author":"A Takawale","year":"2014","unstructured":"Takawale, A. et al. Myocardial recovery from ischemia-reperfusion is compromised in the absence of tissue inhibitor of metalloproteinase 4. Circ. Heart. Fail. 7, 652\u2013662 (2014).","journal-title":"Circ. Heart. Fail."},{"key":"725_CR45","doi-asserted-by":"publisher","first-page":"e022077","DOI":"10.1161\/JAHA.121.022077","volume":"10","author":"Z Dai","year":"2021","unstructured":"Dai, Z. et al. Loss of endothelial hypoxia inducible factor-prolyl hydroxylase 2 induces cardiac hypertrophy and fibrosis. J. Am. Heart Assoc. 10, e022077 (2021).","journal-title":"J. Am. Heart Assoc."},{"key":"725_CR46","doi-asserted-by":"publisher","unstructured":"Tirronen, A. et al. The ablation of VEGFR-1 signaling promotes pressure overload-induced cardiac dysfunction and sudden death. Biomolecules https:\/\/doi.org\/10.3390\/biom11030452 (2021).","DOI":"10.3390\/biom11030452"},{"key":"725_CR47","doi-asserted-by":"publisher","unstructured":"Ullah, K., Ai, L., Humayun, Z. & Wu, R. Targeting endothelial HIF2\u03b1\/ARNT expression for ischemic heart disease therapy. Biology https:\/\/doi.org\/10.3390\/biology12070995 (2023).","DOI":"10.3390\/biology12070995"},{"key":"725_CR48","doi-asserted-by":"publisher","first-page":"H224","DOI":"10.1152\/ajpheart.00108.2017","volume":"313","author":"A Takawale","year":"2017","unstructured":"Takawale, A. et al. Myocardial overexpression of TIMP3 after myocardial infarction exerts beneficial effects by promoting angiogenesis and suppressing early proteolysis. Am. J. Physiol. Heart Circ. Physiol. 313, H224\u2013H236 (2017).","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"725_CR49","doi-asserted-by":"publisher","DOI":"10.1002\/ctm2.1296","volume":"13","author":"G Lu","year":"2023","unstructured":"Lu, G. et al. BMP6 knockdown enhances cardiac fibrosis in a mouse myocardial infarction model by upregulating AP-1\/CEMIP expression. Clin. Transl. Med. 13, e1296 (2023).","journal-title":"Clin. Transl. Med."},{"key":"725_CR50","doi-asserted-by":"publisher","unstructured":"Wright, L. H., Herr, D. J., Brown, S. S., Kasiganesan, H. & Menick, D. R. Angiokine Wisp-1 is increased in myocardial infarction and regulates cardiac endothelial signaling. JCI Insight https:\/\/doi.org\/10.1172\/jci.insight.95824 (2018).","DOI":"10.1172\/jci.insight.95824"},{"key":"725_CR51","doi-asserted-by":"publisher","first-page":"2049","DOI":"10.1016\/j.ijcard.2013.01.165","volume":"168","author":"J Gravning","year":"2013","unstructured":"Gravning, J., Ahmed, M. S., von Lueder, T. G., Edvardsen, T. & Attramadal, H. CCN2\/CTGF attenuates myocardial hypertrophy and cardiac dysfunction upon chronic pressure-overload. Int. J. Cardiol. 168, 2049\u20132056 (2013).","journal-title":"Int. J. Cardiol."},{"key":"725_CR52","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/j.yjmcc.2018.07.130","volume":"121","author":"LE Dorn","year":"2018","unstructured":"Dorn, L. E., Petrosino, J. M., Wright, P. & Accornero, F. CTGF\/CCN2 is an autocrine regulator of cardiac fibrosis. J. Mol. Cell. Cardiol. 121, 205\u2013211 (2018).","journal-title":"J. Mol. Cell. Cardiol."},{"key":"725_CR53","doi-asserted-by":"publisher","first-page":"1142612","DOI":"10.3389\/fcvm.2023.1142612","volume":"10","author":"MA Flinn","year":"2023","unstructured":"Flinn, M. A. et al. Myofibroblast Ccn3 is regulated by Yap and Wwtr1 and contributes to adverse cardiac outcomes. Front. Cardiovasc. Med. 10, 1142612 (2023).","journal-title":"Front. Cardiovasc. Med."},{"key":"725_CR54","doi-asserted-by":"publisher","first-page":"797137","DOI":"10.3389\/fcvm.2022.797137","volume":"9","author":"Y Zha","year":"2022","unstructured":"Zha, Y. et al. ADAMTS8 promotes cardiac fibrosis partly through activating EGFR dependent pathway. Front. Cardiovasc. Med. 9, 797137 (2022).","journal-title":"Front. Cardiovasc. Med."},{"key":"725_CR55","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1161\/CIRCRESAHA.122.320781","volume":"132","author":"Y Sun","year":"2023","unstructured":"Sun, Y. et al. Inhibition of Fap promotes cardiac repair by stabilizing BNP. Circ. Res. 132, 586\u2013600 (2023).","journal-title":"Circ. Res."},{"key":"725_CR56","doi-asserted-by":"publisher","first-page":"3770","DOI":"10.1172\/JCI94753","volume":"127","author":"H Khalil","year":"2017","unstructured":"Khalil, H. et al. Fibroblast-specific TGF-\u03b2-Smad2\/3 signaling underlies cardiac fibrosis. J. Clin. Invest. 127, 3770\u20133783 (2017).","journal-title":"J. Clin. Invest."},{"key":"725_CR57","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.yjmcc.2013.10.019","volume":"70","author":"J Davis","year":"2014","unstructured":"Davis, J. & Molkentin, J. D. Myofibroblasts: trust your heart and let fate decide. J. Mol. Cell. Cardiol. 70, 9\u201318 (2014).","journal-title":"J. Mol. Cell. Cardiol."},{"key":"725_CR58","doi-asserted-by":"publisher","DOI":"10.1038\/s41580-024-00716-0","author":"FS Younesi","year":"2024","unstructured":"Younesi, F. S., Miller, A. E., Barker, T. H., Rossi, F. M. V. & Hinz, B. Fibroblast and myofibroblast activation in normal tissue repair and fibrosis. Nat. Rev. Mol. Cell Biol. https:\/\/doi.org\/10.1038\/s41580-024-00716-0 (2024).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"725_CR59","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1161\/CIRCRESAHA.121.319373","volume":"131","author":"G Garoffolo","year":"2022","unstructured":"Garoffolo, G. et al. Reduction of cardiac fibrosis by interference with YAP-dependent transactivation. Circ. Res. 131, 239\u2013257 (2022).","journal-title":"Circ. Res."},{"key":"725_CR60","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1358\/mf.2003.25.2.723680","volume":"25","author":"P Lijnen","year":"2003","unstructured":"Lijnen, P., Petrov, V., Rumilla, K. & Fagard, R. Transforming growth factor-\u03b2 1 promotes contraction of collagen gel by cardiac fibroblasts through their differentiation into myofibroblasts. Methods Find. Exp. Clin. Pharmacol. 25, 79\u201386 (2003).","journal-title":"Methods Find. Exp. Clin. Pharmacol."},{"key":"725_CR61","doi-asserted-by":"publisher","first-page":"1863","DOI":"10.1016\/j.ajpath.2012.01.022","volume":"180","author":"GC Koenig","year":"2012","unstructured":"Koenig, G. C. et al. MT1-MMP-dependent remodeling of cardiac extracellular matrix structure and function following myocardial infarction. Am. J. Pathol. 180, 1863\u20131878 (2012).","journal-title":"Am. J. Pathol."},{"key":"725_CR62","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.matbio.2021.05.005","volume":"99","author":"A Hanna","year":"2021","unstructured":"Hanna, A. et al. Collagen denaturation in the infarcted myocardium involves temporally distinct effects of MT1-MMP-dependent proteolysis and mechanical tension. Matrix Biol. 99, 18\u201342 (2021).","journal-title":"Matrix Biol."},{"key":"725_CR63","doi-asserted-by":"publisher","first-page":"13461","DOI":"10.1074\/jbc.M113.529115","volume":"289","author":"SE Hiemer","year":"2014","unstructured":"Hiemer, S. E., Szymaniak, A. D. & Varelas, X. The transcriptional regulators TAZ and YAP direct transforming growth factor \u03b2-induced tumorigenic phenotypes in breast cancer cells. J. Biol. Chem. 289, 13461\u201313474 (2014).","journal-title":"J. Biol. Chem."},{"key":"725_CR64","doi-asserted-by":"publisher","first-page":"L344","DOI":"10.1152\/ajplung.00300.2014","volume":"308","author":"F Liu","year":"2015","unstructured":"Liu, F. et al. Mechanosignaling through YAP and TAZ drives fibroblast activation and fibrosis. Am. J. Physiol. Lung Cell. Mol. Physiol. 308, L344\u2013L357 (2015).","journal-title":"Am. J. Physiol. Lung Cell. Mol. Physiol."},{"key":"725_CR65","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1016\/j.jacbts.2020.07.009","volume":"5","author":"J Francisco","year":"2020","unstructured":"Francisco, J. et al. Blockade of fibroblast YAP attenuates cardiac fibrosis and dysfunction through MRTF-A inhibition. JACC Basic Transl. Sci. 5, 931\u2013945 (2020).","journal-title":"JACC Basic Transl. Sci."},{"key":"725_CR66","doi-asserted-by":"publisher","first-page":"1785","DOI":"10.1093\/cvr\/cvab205","volume":"118","author":"MM Mia","year":"2022","unstructured":"Mia, M. M. et al. Loss of Yap\/Taz in cardiac fibroblasts attenuates adverse remodelling and improves cardiac function. Cardiovasc. Res. 118, 1785\u20131804 (2022).","journal-title":"Cardiovasc. Res."},{"key":"725_CR67","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1161\/CIRCRESAHA.119.315069","volume":"125","author":"B Chen","year":"2019","unstructured":"Chen, B. et al. Macrophage Smad3 protects the infarcted heart, stimulating phagocytosis and regulating inflammation. Circ. Res. 125, 55\u201370 (2019).","journal-title":"Circ. Res."},{"key":"725_CR68","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1007\/s00018-013-1349-6","volume":"71","author":"P Kong","year":"2014","unstructured":"Kong, P., Christia, P. & Frangogiannis, N. G. The pathogenesis of cardiac fibrosis. Cell. Mol. Life Sci. 71, 549\u2013574 (2014).","journal-title":"Cell. Mol. Life Sci."},{"key":"725_CR69","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/j.ajpath.2011.09.033","volume":"180","author":"U Hofmann","year":"2012","unstructured":"Hofmann, U. et al. A collagen \u03b12(I) mutation impairs healing after experimental myocardial infarction. Am. J. Pathol. 180, 113\u2013122 (2012).","journal-title":"Am. J. Pathol."},{"key":"725_CR70","doi-asserted-by":"publisher","first-page":"1859","DOI":"10.1681\/ASN.2018020138","volume":"29","author":"S Buchtler","year":"2018","unstructured":"Buchtler, S. et al. Cellular origin and functional relevance of collagen I production in the kidney. J. Am. Soc. Nephrol. 29, 1859\u20131873 (2018).","journal-title":"J. Am. Soc. Nephrol."},{"key":"725_CR71","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1161\/CIRCULATIONAHA.116.026238","volume":"136","author":"JD Molkentin","year":"2017","unstructured":"Molkentin, J. D. et al. Fibroblast-specific genetic manipulation of p38 mitogen-activated protein kinase in vivo reveals its central regulatory role in fibrosis. Circulation 136, 549\u2013561 (2017).","journal-title":"Circulation"},{"key":"725_CR72","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1038\/s41569-022-00799-2","volume":"20","author":"M Pesce","year":"2023","unstructured":"Pesce, M. et al. Cardiac fibroblasts and mechanosensation in heart development, health and disease. Nat. Rev. Cardiol. 20, 309\u2013324 (2023).","journal-title":"Nat. Rev. Cardiol."},{"key":"725_CR73","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1016\/j.cardiores.2003.12.018","volume":"61","author":"J Papakrivopoulou","year":"2004","unstructured":"Papakrivopoulou, J., Lindahl, G. E., Bishop, J. E. & Laurent, G. J. Differential roles of extracellular signal-regulated kinase 1\/2 and p38MAPK in mechanical load-induced procollagen \u03b11(I) gene expression in cardiac fibroblasts. Cardiovasc. Res. 61, 736\u2013744 (2004).","journal-title":"Cardiovasc. Res."},{"key":"725_CR74","doi-asserted-by":"publisher","first-page":"1938","DOI":"10.1161\/01.CIR.0000127126.73759.23","volume":"109","author":"DJ Lips","year":"2004","unstructured":"Lips, D. J. et al. MEK1-ERK2 signaling pathway protects myocardium from ischemic injury in vivo. Circulation 109, 1938\u20131941 (2004).","journal-title":"Circulation"},{"key":"725_CR75","doi-asserted-by":"publisher","first-page":"173ra125","DOI":"10.1126\/scitranslmed.3005503","volume":"5","author":"SB Seif-Naraghi","year":"2013","unstructured":"Seif-Naraghi, S. B. et al. Safety and efficacy of an injectable extracellular matrix hydrogel for treating myocardial infarction. Sci. Transl. Med. 5, 173ra125 (2013).","journal-title":"Sci. Transl. Med."},{"key":"725_CR76","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1016\/j.jacbts.2019.07.012","volume":"4","author":"JH Traverse","year":"2019","unstructured":"Traverse, J. H. et al. First-in-man study of a cardiac extracellular matrix hydrogel in early and late myocardial infarction patients. JACC Basic Transl. Sci. 4, 659\u2013669 (2019).","journal-title":"JACC Basic Transl. Sci."},{"key":"725_CR77","doi-asserted-by":"publisher","first-page":"H1754","DOI":"10.1152\/ajpheart.01199.2005","volume":"291","author":"A Curcio","year":"2006","unstructured":"Curcio, A. et al. Competitive displacement of phosphoinositide 3-kinase from \u03b2-adrenergic receptor kinase-1 improves postinfarction adverse myocardial remodeling. Am. J. Physiol. Heart Circ. Physiol. 291, H1754\u2013H1760 (2006).","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"725_CR78","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1126\/science.abm0594","volume":"375","author":"JG Rurik","year":"2022","unstructured":"Rurik, J. G. et al. CAR T cells produced in vivo to treat cardiac injury. Science 375, 91\u201396 (2022).","journal-title":"Science"},{"key":"725_CR79","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1038\/s41586-019-1546-z","volume":"573","author":"H Aghajanian","year":"2019","unstructured":"Aghajanian, H. et al. Targeting cardiac fibrosis with engineered T cells. Nature 573, 430\u2013433 (2019).","journal-title":"Nature"},{"key":"725_CR80","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-15833-5","volume":"11","author":"G Fulgenzi","year":"2020","unstructured":"Fulgenzi, G. et al. Novel metabolic role for BDNF in pancreatic \u03b2-cell insulin secretion. Nat. Commun. 11, 1950 (2020).","journal-title":"Nat. Commun."},{"key":"725_CR81","doi-asserted-by":"publisher","first-page":"3573","DOI":"10.1016\/j.cell.2021.04.048","volume":"184","author":"Y Hao","year":"2021","unstructured":"Hao, Y. et al. Integrated analysis of multimodal single-cell data. Cell 184, 3573\u20133587 e3529 (2021).","journal-title":"Cell"},{"key":"725_CR82","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1016\/j.cels.2019.03.003","volume":"8","author":"CS McGinnis","year":"2019","unstructured":"McGinnis, C. S., Murrow, L. M. & Gartner, Z. J. DoubletFinder: doublet detection in single-cell RNA sequencing data using artificial nearest neighbors. Cell Syst. 8, 329\u2013337 e324 (2019).","journal-title":"Cell Syst."},{"key":"725_CR83","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-014-0550-8","volume":"15","author":"MI Love","year":"2014","unstructured":"Love, M. I., Huber, W. & Anders, S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 15, 550 (2014).","journal-title":"Genome Biol"},{"key":"725_CR84","first-page":"100141","volume":"2","author":"T Wu","year":"2021","unstructured":"Wu, T. et al. clusterProfiler 4.0: a universal enrichment tool for interpreting omics data. Innovation 2, 100141 (2021).","journal-title":"Innovation"},{"key":"725_CR85","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1038\/s41586-018-0414-6","volume":"560","author":"G La Manno","year":"2018","unstructured":"La Manno, G. et al. RNA velocity of single cells. Nature 560, 494\u2013498 (2018).","journal-title":"Nature"},{"key":"725_CR86","doi-asserted-by":"publisher","first-page":"1408","DOI":"10.1038\/s41587-020-0591-3","volume":"38","author":"V Bergen","year":"2020","unstructured":"Bergen, V., Lange, M., Peidli, S., Wolf, F. A. & Theis, F. J. Generalizing RNA velocity to transient cell states through dynamical modeling. Nat. Biotechnol. 38, 1408\u20131414 (2020).","journal-title":"Nat. Biotechnol."},{"key":"725_CR87","doi-asserted-by":"publisher","unstructured":"Melzer, M., Beier, D., Young, P. P. & Saraswati, S. Isolation and characterization of adult cardiac fibroblasts and myofibroblasts. J. Vis. Exp. https:\/\/doi.org\/10.3791\/60909 (2020).","DOI":"10.3791\/60909"},{"key":"725_CR88","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1038\/nbt0502-473","volume":"20","author":"S Fredriksson","year":"2002","unstructured":"Fredriksson, S. et al. Protein detection using proximity-dependent DNA ligation assays. Nat. Biotechnol. 20, 473\u2013477 (2002).","journal-title":"Nat. Biotechnol."},{"key":"725_CR89","doi-asserted-by":"publisher","first-page":"9825","DOI":"10.1021\/acsnano.7b03150","volume":"11","author":"J Hwang","year":"2017","unstructured":"Hwang, J. et al. In situ imaging of tissue remodeling with collagen hybridizing peptides. ACS Nano. 11, 9825\u20139835 (2017).","journal-title":"ACS Nano."},{"key":"725_CR90","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1016\/j.molcel.2023.11.035","volume":"84","author":"V Osei-Amponsa","year":"2024","unstructured":"Osei-Amponsa, V. et al. hRpn13 shapes the proteome and transcriptome through epigenetic factors HDAC8, PADI4, and transcription factor NF-\u03baB p50. Mol. Cell 84, 522\u2013537 e528 (2024).","journal-title":"Mol. Cell"},{"key":"725_CR91","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-14433-7","volume":"11","author":"EM Palmieri","year":"2020","unstructured":"Palmieri, E. M. et al. Nitric oxide orchestrates metabolic rewiring in M1 macrophages by targeting aconitase 2 and pyruvate dehydrogenase. Nat. Commun. 11, 698 (2020).","journal-title":"Nat. Commun."},{"key":"725_CR92","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1016\/j.ccell.2017.03.005","volume":"31","author":"S Seaman","year":"2017","unstructured":"Seaman, S. et al. Eradication of tumors through simultaneous ablation of CD276\/B7-H3-positive tumor cells and tumor vasculature. Cancer Cell 31, 501\u2013515 e508 (2017).","journal-title":"Cancer Cell"},{"key":"725_CR93","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1093\/nar\/30.1.245","volume":"30","author":"J Westbrook","year":"2002","unstructured":"Westbrook, J. et al. The Protein Data Bank: unifying the archive. Nucleic Acids Res. 30, 245\u2013248 (2002).","journal-title":"Nucleic Acids Res."},{"key":"725_CR94","doi-asserted-by":"publisher","first-page":"e11203","DOI":"10.1371\/journal.pone.0011203","volume":"5","author":"S Fu","year":"2010","unstructured":"Fu, S. et al. The structure of tumor endothelial marker 8 (TEM8) extracellular domain and implications for its receptor function for recognizing anthrax toxin. PLoS ONE 5, e11203 (2010).","journal-title":"PLoS ONE"},{"key":"725_CR95","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1016\/j.jmb.2015.09.014","volume":"428","author":"GCP van Zundert","year":"2016","unstructured":"van Zundert, G. C. P. et al. The HADDOCK2.2 web server: user-friendly integrative modeling of biomolecular complexes. J. Mol. Biol. 428, 720\u2013725 (2016).","journal-title":"J. Mol. Biol."},{"key":"725_CR96","doi-asserted-by":"publisher","first-page":"729513","DOI":"10.3389\/fmolb.2021.729513","volume":"8","author":"RV Honorato","year":"2021","unstructured":"Honorato, R. V. et al. Structural biology in the clouds: the WeNMR-EOSC ecosystem. Front. Mol. Biosci. 8, 729513 (2021).","journal-title":"Front. Mol. Biosci."}],"container-title":["Nature Cardiovascular Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s44161-025-00725-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s44161-025-00725-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s44161-025-00725-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T15:02:16Z","timestamp":1762959736000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s44161-025-00725-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,2]]},"references-count":96,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2025,11]]}},"alternative-id":["725"],"URL":"https:\/\/doi.org\/10.1038\/s44161-025-00725-y","relation":{},"ISSN":["2731-0590"],"issn-type":[{"value":"2731-0590","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,2]]},"assertion":[{"value":"29 July 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"N.B., G.Y., J.M.D., L.T. and B.S.C. are NIH inventors of a provisional patent application (International application number PCT\/US2025\/017061) filed by the USA, as represented by the Secretary, Department of Health and Human Services, for the use of ANTXR1 antibodies for treatment of heart disease. The key finding, showing that anti-ANTXR1 antibodies can improve outcomes in heart disease, is revealed in the patent. B.S.C. is also an NIH inventor on a granted patent application (US application no. 9,181,340) filed by the USA, as represented by the Secretary, Department of Health and Human Services, that describes the initial development of the L2 anti-ANTXR1 antibody. This granted patent application does not cover specific aspects of this paper, such as the role of ANTXR1 in heart disease. The other authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}